Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003788)

HILIC NEGATIVE ION MODE (Analysis AN006445)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16	F17	F18	F19	F20	F21	F22	F23	F24	F25	F26	F27	F28	F29	F30	F31	F32	F33	F34	F35	F36	F37	F38	F39	F40	F41	F42	F43	F44	F45	F46	F47	F48	F49	F50	F51	F52	F53	F54	F55	F56	F57	F58	F59	F60	F61
taurocholate	ME1042318	NA	NA	0.93	NA	1.02	NA	2.35	0.33	NA	NA	NA	NA	0.05	NA	0.45	NA	0.29	7.15	NA	NA	0.09	1.26	0.16	0.05	NA	NA	25.02	NA	NA	0.42	0.99	NA	NA	0.05	NA	0.35	0.04	NA	NA	NA	0.27	0.18	0.29	NA	NA	NA	0.76	0.05	NA	1.26	0.26	0.03	0.61	NA	NA	NA	0.67	0.59	NA	1.97	2.91
pyruvate	ME1042308	8.63	22.41	2.21	0.74	0.78	0.65	0.96	1.26	0.63	0.80	0.62	0.97	0.67	1.34	0.99	1.07	2.85	1.65	0.58	0.71	1.07	1.10	1.50	0.65	0.69	0.76	0.73	0.75	0.76	0.74	1.08	0.72	2.21	1.74	0.81	0.84	0.88	0.46	1.20	0.91	0.85	0.76	0.64	0.38	2.05	0.42	1.00	0.82	1.43	0.79	0.90	0.85	0.86	1.06	0.55	0.32	0.67	0.84	0.64	3.88	0.31
tartarate	ME1042317	0.12	NA	NA	NA	NA	0.29	0.21	14.99	NA	NA	0.02	0.05	NA	NA	0.02	NA	NA	0.03	NA	0.21	0.07	0.39	0.19	1.35	0.10	0.09	0.12	NA	0.06	1.28	0.09	0.05	NA	NA	0.05	0.98	1.33	2.44	0.04	0.41	0.04	0.42	0.27	1.65	0.74	2.33	0.04	0.19	0.43	0.99	1.33	0.17	0.17	0.24	0.17	NA	1.38	0.50	0.10	0.72	0.25
sorbitol	ME1042312	0.21	0.16	0.31	0.22	0.23	0.20	0.27	0.19	0.13	0.17	0.15	0.28	0.11	0.09	0.20	0.20	0.42	0.21	0.15	0.25	0.20	0.22	0.28	0.18	0.12	0.38	0.18	0.15	0.45	0.14	0.18	0.17	2.25	0.50	0.17	2.18	1.92	7.58	0.31	0.28	0.28	1.65	0.25	11.56	0.50	0.22	0.35	0.36	4.01	1.49	2.35	6.22	1.39	1.52	0.29	0.50	0.88	1.10	0.14	0.52	1.32
aspartate	ME1042276	1.03	13.64	1.62	0.06	0.12	0.15	0.71	0.92	0.40	0.36	0.19	0.22	NA	0.02	0.51	0.08	0.69	0.40	0.08	0.07	0.09	0.64	1.03	0.25	0.09	0.16	1.16	0.37	NA	0.25	0.54	0.25	0.13	0.16	0.04	0.86	0.65	3.20	NA	0.62	NA	1.27	0.82	3.45	0.06	1.26	0.30	NA	0.76	0.78	0.91	0.58	0.68	0.12	0.74	NA	1.78	1.92	0.73	1.54	1.37
hypoxanthine	ME1042291	3.32	8.86	3.95	1.02	0.78	0.91	0.74	1.02	0.68	1.34	0.42	1.02	0.59	0.51	0.83	3.08	1.85	1.93	1.80	0.83	0.82	0.92	1.42	0.99	0.71	0.61	0.61	0.89	1.34	0.81	0.76	0.28	1.70	0.77	2.38	0.75	0.82	0.78	1.28	0.86	0.69	0.91	0.89	0.60	0.72	0.73	0.84	1.11	0.93	0.87	0.65	1.33	0.62	0.57	0.96	0.68	0.96	1.41	1.39	3.81	0.72
guanosine	ME1042287	0.69	0.38	0.79	0.50	0.15	0.17	0.36	0.49	NA	0.15	0.11	0.32	NA	NA	0.18	1.03	0.86	4.52	0.12	0.11	0.13	0.50	0.37	0.12	0.16	1.77	0.33	0.17	0.25	0.94	0.49	0.08	NA	NA	NA	0.55	0.44	0.71	0.08	1.69	0.57	0.55	0.65	NA	0.72	NA	0.34	0.23	0.37	0.62	0.48	0.50	0.18	0.23	0.47	NA	0.61	0.93	1.07	10.48	0.40
inosine	ME1042294	0.87	2.82	1.72	0.90	1.06	0.95	0.37	0.48	0.19	0.64	0.40	1.05	0.79	0.36	0.72	1.81	2.31	1.94	1.35	0.88	0.81	0.54	0.61	0.61	0.50	0.85	0.68	1.06	1.04	0.58	0.58	0.38	2.80	1.11	0.54	0.78	0.73	0.77	0.63	1.81	1.11	1.67	1.26	0.61	0.87	0.89	1.28	0.95	5.24	0.92	1.10	0.80	0.62	0.64	0.95	0.74	1.22	1.14	1.40	6.59	1.17
adipate/methylglutarate	ME1042269	2.62	1.16	0.62	0.54	0.69	0.75	0.99	0.97	0.72	0.70	0.72	0.94	0.85	0.63	1.12	1.14	0.87	0.70	0.36	0.72	0.61	0.78	0.84	0.66	0.58	0.62	0.78	0.53	0.69	0.97	0.68	0.69	0.58	0.91	1.03	1.01	0.87	10.08	0.77	0.72	0.58	1.17	1.24	0.88	0.80	1.30	0.66	0.79	1.69	1.04	1.25	0.98	0.71	0.61	1.15	0.58	1.17	1.29	1.44	0.94	1.06
hippurate	ME1042288	NA	0.38	NA	0.02	0.01	0.57	1.64	2.12	4.16	0.03	0.20	0.80	NA	NA	0.12	0.05	0.01	0.72	NA	0.00	0.02	2.08	1.71	0.44	NA	0.10	0.10	0.01	NA	0.23	1.48	0.04	NA	NA	NA	0.47	0.47	NA	NA	NA	0.02	0.52	0.49	0.03	NA	0.02	NA	0.10	0.15	0.61	0.38	4.92	0.05	0.27	0.87	NA	0.62	0.61	NA	0.17	0.26
sucrose/lactose/trehalose	ME1042316	0.21	0.58	0.66	0.13	0.31	0.18	0.79	0.92	0.20	1.10	0.90	0.48	0.20	0.03	1.47	0.65	0.38	0.21	0.26	0.28	0.19	0.82	2.14	0.31	0.41	5.06	0.97	0.06	0.13	0.86	1.42	0.41	0.12	0.43	0.18	0.55	0.51	1.44	1.45	3.31	0.51	0.58	2.84	0.51	0.12	0.39	0.18	1.29	0.30	0.63	1.55	0.87	2.21	3.08	1.53	0.27	1.13	1.38	0.18	1.46	3.07
sebacate	ME1042311	1.02	2.12	0.91	0.63	0.88	0.80	1.15	1.15	0.88	0.71	0.78	1.09	1.17	0.83	0.76	0.61	0.99	0.81	0.40	0.88	0.68	0.92	1.20	0.82	0.53	0.70	0.86	0.50	0.82	0.74	0.83	0.71	0.80	6.95	0.93	0.93	1.23	0.86	2.78	0.61	0.67	0.86	0.95	0.74	0.78	0.83	0.68	0.82	0.80	0.87	1.00	0.86	0.65	0.67	0.64	0.80	0.90	1.08	0.78	0.93	3.11
4-hydroxybenzeneacetonitrile	ME1042264	0.87	NA	0.87	NA	1.62	0.19	1.03	1.07	NA	NA	0.29	NA	NA	NA	0.37	NA	1.01	NA	NA	NA	1.03	0.67	0.83	NA	NA	0.34	NA	NA	0.48	0.42	0.41	NA	NA	1.46	NA	1.13	1.07	NA	NA	NA	5.02	1.59	0.39	0.27	0.25	NA	2.25	NA	0.64	0.87	1.47	1.21	0.36	0.38	0.30	3.16	1.10	0.83	0.11	0.80	1.70
ranitidine	ME1042310	4.37	2.76	0.21	NA	0.21	0.12	1.31	2.30	0.82	NA	0.00	NA	NA	1.28	0.37	0.16	NA	0.87	0.21	0.00	0.08	1.48	1.88	0.05	NA	0.02	0.01	NA	NA	0.38	0.31	NA	NA	0.02	NA	0.25	0.03	NA	NA	NA	NA	0.01	0.00	NA	NA	NA	NA	0.00	NA	0.24	0.00	0.00	NA	0.00	0.00	NA	0.03	0.03	NA	0.03	0.16
1-methylurate	ME1042255	0.54	1.06	0.60	NA	NA	4.24	1.00	1.38	0.29	0.45	0.23	1.51	NA	0.40	0.68	NA	1.34	1.04	NA	0.30	0.30	1.03	1.62	0.69	0.17	0.68	0.89	NA	NA	0.51	0.45	NA	0.59	0.30	NA	0.87	1.15	NA	NA	NA	NA	2.23	0.70	0.39	NA	0.37	0.89	NA	0.26	0.75	1.51	0.70	NA	0.30	NA	NA	0.92	0.95	0.31	0.91	0.43
indoxylsulfate	ME1042293	0.36	1.70	0.10	0.03	NA	0.50	1.60	2.17	0.68	0.08	0.22	1.80	0.04	0.16	0.14	NA	0.75	0.34	NA	NA	0.06	1.16	1.91	0.75	NA	0.38	0.18	NA	0.08	0.19	4.51	0.06	0.14	0.04	NA	0.45	0.68	NA	NA	NA	NA	0.47	0.43	0.09	0.35	0.03	0.04	0.45	0.06	0.47	0.45	0.28	0.16	0.32	NA	NA	1.07	1.64	NA	0.33	0.71
cytidine	ME1042279	0.09	NA	NA	0.98	2.48	1.53	0.65	0.97	NA	NA	1.86	2.27	0.99	NA	0.67	1.03	1.29	0.99	1.01	2.27	0.91	0.54	1.04	0.30	NA	0.85	0.19	1.27	0.90	0.55	1.47	NA	NA	NA	NA	1.22	0.35	NA	0.29	NA	0.98	1.09	1.08	NA	NA	NA	1.83	1.25	NA	1.06	1.84	NA	1.81	0.65	0.27	2.11	0.72	1.13	NA	0.80	0.96
acetaminophen glucuronide	ME1042266	0.11	0.08	0.24	NA	0.03	0.08	0.79	2.07	NA	0.25	0.20	0.52	NA	0.40	0.22	NA	0.44	0.24	0.05	0.01	0.04	0.81	1.09	0.93	NA	0.22	0.43	NA	0.21	0.34	0.30	0.54	1.32	0.49	NA	1.01	1.18	NA	0.06	0.22	0.50	0.93	0.49	4.38	1.00	1.00	1.89	0.69	0.22	1.06	1.69	1.28	0.46	1.01	0.42	0.07	1.46	0.68	0.11	0.75	0.47
CMPF	ME1042278	1.22	0.03	0.20	0.09	NA	0.36	0.75	0.64	NA	0.17	0.06	NA	NA	0.13	0.21	1.33	0.26	0.79	NA	0.04	0.04	0.47	0.60	0.36	0.01	0.02	0.26	0.03	NA	0.17	0.46	0.13	2.48	0.51	0.37	1.04	1.04	1.45	0.02	0.03	0.07	0.61	0.22	0.65	2.07	0.07	0.48	1.17	0.58	1.28	0.90	0.21	0.85	0.73	0.06	0.05	1.04	1.64	0.26	3.39	0.91
ethyl glucuronide	ME1042281	NA	NA	NA	NA	0.16	0.08	0.30	0.33	0.16	NA	NA	NA	NA	NA	NA	0.04	NA	0.05	NA	0.01	0.09	0.26	0.25	0.02	NA	NA	NA	NA	0.02	0.02	0.01	NA	0.01	0.03	NA	1.12	0.79	3.05	NA	1.32	NA	1.36	1.47	2.80	0.02	1.65	0.47	NA	0.33	0.95	1.51	0.61	0.48	0.02	1.42	NA	1.61	1.63	3.43	0.44	1.33
glutamate	ME1042285	0.30	0.92	0.78	0.03	0.01	0.01	0.42	0.35	0.16	0.07	0.03	0.01	NA	0.01	0.10	0.18	0.47	0.34	0.01	0.01	0.01	0.32	0.34	0.10	0.02	0.06	0.14	0.01	0.00	0.11	0.13	0.17	0.14	NA	NA	0.75	0.54	1.58	NA	1.00	0.01	1.36	1.92	1.76	0.06	0.71	0.03	0.02	0.55	0.71	0.82	0.97	0.67	0.03	0.42	NA	2.43	2.74	1.12	2.78	2.46
oxalate	ME1042305	0.34	0.85	0.11	0.30	0.21	0.31	0.61	0.82	0.50	0.24	0.19	0.67	0.14	0.15	0.21	0.41	0.46	0.19	1.40	0.11	0.24	0.62	0.62	0.36	0.25	0.19	0.19	0.12	0.10	0.26	0.29	0.28	0.38	0.46	0.82	1.31	1.05	1.74	0.23	1.23	0.30	1.15	0.95	1.50	0.43	1.08	0.37	0.20	1.23	1.26	1.58	1.17	0.84	0.43	1.48	0.26	1.25	1.62	1.12	1.46	1.39
2-isopropylmalate	ME1042261	0.00	NA	NA	NA	0.09	0.06	0.12	0.13	0.08	0.02	0.03	NA	NA	NA	0.03	0.05	NA	NA	0.04	0.01	0.05	0.12	0.15	0.07	0.04	0.34	0.03	NA	0.00	0.16	0.12	NA	NA	NA	0.05	1.38	1.56	0.91	0.26	1.19	NA	1.42	1.89	1.82	0.03	0.74	0.02	NA	0.28	1.31	1.15	0.36	1.59	1.04	2.27	NA	1.46	1.57	0.99	1.70	1.26
2-hydroxyglutarate	ME1042260	0.34	0.08	0.07	0.05	0.35	0.34	0.60	0.65	0.49	0.07	0.03	0.04	0.03	0.08	0.13	0.45	0.08	0.28	0.17	0.10	0.35	0.52	0.48	0.12	0.07	0.10	0.08	0.05	0.13	0.15	0.18	0.05	0.11	0.19	0.18	1.38	1.19	1.22	0.13	1.12	0.16	1.61	1.36	1.56	0.18	1.09	0.18	0.10	0.47	1.26	1.32	0.24	0.72	0.09	2.27	0.06	1.41	1.60	0.99	1.01	1.86
itaconate	ME1042296	0.39	0.14	0.08	0.09	0.40	0.39	0.61	0.66	0.51	0.07	0.07	0.11	0.15	0.14	0.18	0.46	0.08	0.27	0.18	0.18	0.36	0.53	0.49	0.21	0.08	0.13	0.11	0.09	0.13	0.18	0.23	0.07	0.14	0.19	0.28	1.39	1.17	1.22	0.16	1.10	0.13	1.59	1.29	1.38	0.24	1.06	0.31	0.16	0.56	1.25	1.31	0.26	0.77	0.19	2.19	NA	1.38	1.58	0.94	1.12	1.76
4-pyridoxate	ME1042265	NA	NA	0.18	0.16	NA	0.16	1.67	1.46	NA	NA	0.13	0.68	NA	NA	0.06	0.01	NA	0.03	NA	NA	0.03	1.01	0.84	NA	NA	0.08	0.02	0.01	NA	0.53	0.60	0.08	NA	0.67	0.23	0.93	0.32	NA	NA	0.08	0.02	1.64	0.26	NA	NA	NA	0.15	0.01	0.20	0.76	1.58	0.57	0.11	0.13	0.16	0.03	1.53	0.52	0.20	0.45	0.42
nicotinate	ME1042304	NA	NA	NA	0.14	0.01	NA	0.58	2.09	NA	NA	NA	NA	NA	NA	0.60	NA	NA	NA	NA	NA	0.20	0.81	0.52	0.05	NA	NA	0.03	NA	NA	0.19	0.11	NA	NA	NA	0.14	1.18	1.18	3.45	NA	0.61	NA	0.75	1.24	NA	NA	0.87	NA	NA	0.33	1.14	0.97	2.90	0.57	0.29	0.42	NA	1.20	1.03	0.15	0.05	0.53
methylmalonate	ME1042302	1.60	0.97	1.68	1.15	0.83	0.77	1.01	1.20	1.07	0.59	0.73	0.95	0.62	0.55	0.83	1.46	1.00	0.73	1.92	0.96	0.89	1.18	1.42	0.71	0.60	0.64	0.66	0.86	0.69	0.87	1.04	0.76	0.78	1.17	0.75	0.87	0.96	1.19	0.94	1.31	1.32	0.96	0.73	1.28	0.76	0.44	1.03	0.64	0.32	0.96	0.90	5.40	1.17	1.07	1.25	0.51	0.90	0.93	1.05	0.97	0.94
adenine	ME1042268	1.91	2.54	0.45	0.47	0.28	0.48	0.84	0.98	1.45	0.91	0.55	0.25	0.19	0.26	0.38	0.63	0.76	0.96	1.03	0.25	0.41	0.85	0.89	0.66	1.03	1.16	0.42	0.21	0.22	0.58	0.76	0.65	0.65	0.66	0.48	1.06	1.14	1.12	1.04	4.58	0.75	0.95	1.22	1.36	0.52	0.36	0.35	0.30	0.71	1.06	0.80	1.01	0.63	0.91	1.22	0.41	1.02	1.05	1.95	2.18	2.03
inositol/theophylline	ME1042295	2.12	0.66	1.41	1.15	1.40	1.05	0.90	1.13	0.56	0.97	0.53	1.23	0.69	0.66	0.93	1.68	4.74	1.13	1.04	1.33	0.84	1.03	0.87	0.80	1.85	0.74	0.99	1.45	0.90	1.12	0.89	0.61	1.13	1.08	1.20	0.86	0.91	0.74	0.20	0.52	0.63	1.18	0.89	0.87	1.28	0.98	1.34	0.59	0.67	1.02	0.87	1.25	0.60	1.27	0.96	0.67	1.06	1.05	0.98	1.36	0.85
succinyladenosine	ME1042315	2.07	0.58	1.01	1.10	1.54	1.14	0.76	0.98	0.58	0.74	1.38	2.90	0.83	1.11	1.16	1.90	3.33	1.07	0.89	2.10	1.91	0.76	0.88	0.89	0.72	1.49	1.03	1.18	2.83	1.11	0.94	1.62	2.04	1.18	1.78	0.92	1.11	1.01	0.94	0.99	1.37	1.05	1.23	0.63	0.65	0.95	1.16	1.80	2.67	1.00	1.17	0.96	0.91	1.27	1.72	0.77	1.04	1.05	1.04	0.98	1.44
homovanillate	ME1042289	1.39	4.91	1.16	0.13	0.13	0.11	1.05	1.27	0.74	2.24	0.71	0.71	0.03	0.26	0.53	0.30	0.75	1.08	0.07	0.30	0.19	1.19	1.75	1.19	0.62	1.29	0.60	0.07	0.40	0.63	0.61	0.29	0.99	0.45	0.33	0.80	1.16	1.31	0.75	0.83	0.13	0.88	0.93	0.60	0.23	1.01	0.14	0.13	0.38	0.86	0.88	1.64	1.24	0.73	0.39	NA	1.12	1.48	0.50	0.83	0.73
xanthine	ME1042324	2.38	3.54	1.78	0.34	0.43	0.36	0.84	1.00	0.76	1.30	0.54	0.58	0.29	0.88	0.76	0.65	0.68	1.05	0.40	0.44	0.40	0.97	1.19	1.00	1.35	0.87	0.77	0.34	0.77	0.96	0.75	0.66	2.59	0.85	1.46	1.03	0.99	1.68	1.03	1.00	0.53	1.03	0.94	1.03	0.63	1.09	0.39	0.38	0.48	1.02	1.08	1.16	0.74	0.87	0.95	0.28	1.02	1.13	0.87	1.87	0.92
alpha-keto-beta-methylvalerate/alpha-ketoisocaproate	ME1042272	2.40	6.15	2.57	0.45	0.68	0.39	1.23	1.55	0.80	0.46	0.35	1.01	0.47	0.75	0.62	0.79	0.89	1.19	0.44	0.87	0.61	1.24	1.87	0.85	0.30	0.37	0.50	0.53	0.96	0.60	1.14	0.24	0.58	0.41	0.60	0.78	0.97	0.74	0.62	0.40	0.43	0.70	0.60	0.61	0.75	0.59	0.47	0.35	0.35	0.84	1.13	1.16	0.76	0.33	0.30	0.24	0.96	1.02	0.60	1.28	0.26
mesaconate	ME1042301	1.16	3.14	0.98	0.42	1.62	0.37	0.97	1.12	0.56	0.39	0.41	0.63	0.66	0.45	0.46	1.03	0.58	1.27	0.47	0.54	0.33	0.79	0.95	0.49	0.38	0.54	0.41	0.28	0.27	0.46	0.53	0.33	0.62	0.72	0.29	0.98	0.85	1.74	0.44	0.68	0.55	1.14	1.17	1.59	0.70	0.71	0.36	0.40	0.50	0.93	1.14	1.31	0.61	0.51	0.60	0.29	1.41	1.45	1.47	1.70	1.00
alpha-ketoisovalerate	ME1042273	1.85	3.24	2.12	0.77	0.99	0.61	1.17	1.74	1.02	0.59	0.58	1.46	0.68	0.91	0.97	1.32	1.92	1.15	0.39	1.15	0.83	1.21	1.52	1.15	0.34	0.59	0.91	0.66	1.06	0.79	0.82	0.37	1.05	1.08	0.69	0.84	0.98	0.61	0.94	0.32	0.67	0.73	0.69	0.53	0.94	0.59	0.92	1.06	0.40	0.91	1.25	1.07	0.91	0.78	0.43	0.45	0.88	0.94	0.70	0.92	0.34
thymine	ME1042320	1.42	4.22	0.82	0.75	0.83	0.82	1.09	1.71	0.89	0.73	0.76	1.64	0.40	0.62	1.00	1.33	1.62	0.80	0.71	0.67	0.65	0.96	1.48	0.73	0.44	0.70	0.73	0.50	1.02	0.64	0.82	0.48	0.95	1.12	0.59	0.86	0.95	0.88	0.46	0.83	0.76	1.00	0.94	0.96	0.78	0.89	0.72	1.32	0.76	0.87	1.05	1.07	0.64	0.73	0.82	0.55	1.02	1.07	0.85	1.55	0.66
uracil	ME1042321	1.65	4.70	0.99	0.44	0.50	0.56	1.02	1.40	0.89	0.88	0.55	0.50	0.52	1.50	0.78	0.58	0.70	0.72	0.75	0.56	0.52	0.96	1.40	0.77	0.53	0.72	0.76	0.62	0.27	0.71	0.76	0.51	0.49	1.29	1.26	0.90	0.79	0.67	0.57	1.28	0.62	1.01	0.87	0.99	0.61	1.18	0.62	0.48	0.65	0.93	0.87	0.80	0.73	0.74	1.00	0.64	1.06	1.12	0.98	2.23	0.68
succinate	ME1042314	0.94	4.55	1.35	0.69	0.56	0.58	1.15	1.20	0.90	0.43	0.47	0.64	0.57	0.60	0.61	1.76	0.80	0.91	0.72	0.56	0.50	1.02	1.16	0.61	0.49	0.81	0.58	0.35	0.44	0.62	0.63	0.51	0.61	0.79	0.58	0.90	0.90	1.09	0.61	1.25	1.01	0.98	1.16	1.08	0.95	0.85	0.63	0.62	0.59	0.92	1.08	0.71	1.17	0.69	0.73	0.68	0.99	1.21	0.89	1.24	1.92
fumarate/maleate	ME1042283	1.30	4.56	1.56	0.78	0.71	0.63	1.31	1.41	1.22	0.43	0.59	0.89	0.57	0.64	1.19	1.33	1.86	1.69	0.69	0.63	0.57	1.18	1.21	0.67	0.55	0.87	0.90	0.36	0.64	0.66	0.69	0.55	0.75	0.72	0.60	0.95	1.00	0.62	0.47	0.90	1.11	0.82	1.02	0.96	1.16	0.50	0.52	0.64	0.47	0.78	1.10	1.00	0.86	0.60	0.59	0.37	0.86	0.95	0.51	2.17	0.80
malate	ME1042299	1.29	5.43	1.52	0.74	0.57	0.51	1.43	1.48	1.21	0.33	0.43	0.73	0.35	0.51	1.19	1.62	1.90	1.79	1.20	0.51	0.54	1.27	1.20	0.53	0.54	0.89	0.90	0.36	0.55	0.60	0.63	0.46	0.74	0.62	0.42	0.94	0.95	0.49	0.40	0.87	1.05	0.79	0.96	0.88	1.08	0.39	0.45	0.59	0.47	0.74	1.10	0.99	0.84	0.58	0.54	0.32	0.80	0.90	0.40	2.43	0.70
alpha-hydroxybutyrate/beta-hydroxybutyrate/hydroxyisobutyrate	ME1042290	1.26	1.28	2.07	0.60	1.43	0.72	1.32	1.62	1.04	0.90	1.25	1.60	1.37	1.42	1.11	1.15	1.41	0.97	0.80	1.54	1.13	1.24	1.51	1.05	1.64	1.12	0.75	0.72	2.17	0.71	0.96	0.83	1.26	1.19	0.65	0.84	1.04	0.63	1.80	0.40	0.59	0.77	0.90	0.79	0.98	0.49	0.66	0.56	0.31	0.82	0.91	0.78	0.74	0.73	0.94	0.71	0.78	0.91	0.62	1.13	0.66
2-hydroxy-3-methylbutyrate/hydroxyisovalerate	ME1042258	1.39	1.03	2.00	0.54	1.28	0.63	1.07	1.56	1.00	0.45	0.93	2.58	1.06	0.38	0.88	1.62	1.88	0.81	0.51	2.15	1.32	1.24	1.61	1.39	0.59	0.79	0.86	1.11	2.27	0.69	0.78	0.48	3.44	1.00	0.55	0.73	0.89	0.63	0.99	0.35	0.42	0.84	0.83	0.56	0.63	0.65	2.10	1.50	0.38	0.94	0.99	0.96	0.54	0.64	0.68	0.45	0.81	0.97	0.91	0.89	0.69
2-hydroxy-3-methylpentanoate/hydroxyisocaproate	ME1042259	1.47	2.42	2.43	0.39	1.34	0.51	1.08	1.61	1.11	0.50	0.81	3.95	0.86	0.43	0.94	1.94	2.28	1.09	0.44	2.27	1.12	1.29	1.87	1.37	0.68	0.77	0.80	0.85	2.37	0.62	0.78	0.39	1.83	0.95	0.44	0.74	1.01	0.65	1.05	0.47	0.40	0.80	0.79	0.60	0.66	0.56	1.20	1.34	0.40	0.86	0.91	1.09	0.49	0.51	0.52	0.39	0.78	1.03	0.71	0.91	0.62
N-acetylglutamate	ME1042303	2.46	1.96	0.99	0.92	1.23	0.76	1.07	1.27	1.08	0.35	0.67	1.35	0.73	0.74	0.64	1.78	2.04	0.81	0.91	1.50	1.22	0.96	0.98	0.57	0.51	0.89	0.62	0.79	2.58	0.64	0.70	0.49	0.87	0.56	0.97	1.17	0.86	0.69	0.83	0.79	2.01	1.06	1.11	1.13	0.78	0.58	0.83	0.82	1.68	0.92	0.89	1.11	0.82	0.78	0.88	0.44	0.89	0.86	0.86	1.50	1.18
fructose/glucose/galactose	ME1042282	0.56	0.05	0.31	1.73	1.50	1.56	0.91	0.92	0.85	0.42	0.75	1.16	0.91	0.86	1.00	1.58	1.02	0.65	1.54	1.51	1.45	0.82	0.76	0.93	0.14	0.68	1.10	1.31	1.22	0.85	1.00	0.63	0.38	0.66	1.44	1.01	0.93	0.68	0.77	0.83	1.62	1.06	0.92	1.00	1.25	1.51	2.22	1.38	1.42	1.12	1.21	0.68	1.27	1.16	1.32	1.38	0.99	0.94	0.95	1.04	0.96
erythronate/threonate	ME1042280	1.27	0.81	0.76	1.39	1.35	1.35	0.68	0.94	0.75	1.00	0.62	1.36	0.67	0.68	0.92	1.47	1.65	0.93	2.34	1.19	1.09	0.75	0.71	1.01	0.79	1.20	0.98	0.94	1.48	0.93	1.00	1.39	1.28	0.96	1.45	1.07	1.07	0.98	0.91	1.56	2.07	1.17	1.27	0.87	1.09	0.94	1.52	1.66	2.33	1.10	1.17	0.99	1.19	1.28	1.60	1.19	1.00	1.00	0.96	1.25	1.42
adonitol/arabitol	ME1042270	1.30	1.53	1.33	1.06	1.19	1.24	0.77	1.06	0.81	1.13	1.09	1.81	0.97	1.16	1.17	1.28	1.83	1.20	1.29	1.54	1.31	0.82	0.87	1.13	0.88	1.32	1.10	1.03	1.52	0.92	1.08	1.36	1.02	1.13	1.41	0.99	1.06	0.82	1.30	1.13	1.50	1.08	1.24	0.47	0.91	1.16	1.12	2.02	1.70	1.01	1.10	0.79	1.17	1.30	1.48	0.88	0.98	1.01	0.94	1.22	1.45
threitol	ME1042319	0.95	1.04	0.92	1.35	1.71	1.49	0.85	1.26	0.86	1.15	1.08	1.77	0.94	0.85	1.10	1.48	1.98	1.07	1.18	1.84	1.49	0.83	0.88	1.16	0.56	1.64	1.06	1.03	2.35	0.91	1.12	0.98	0.74	1.18	1.08	1.00	1.19	1.19	1.25	1.27	1.38	1.04	1.09	0.96	0.94	1.33	1.56	2.01	1.39	0.97	1.36	0.62	1.02	1.53	1.37	1.24	0.85	0.98	0.82	1.18	1.26
alpha-glycerophosphate	ME1042271	0.47	0.78	0.13	1.35	0.84	0.89	0.95	0.81	0.84	0.95	0.79	0.56	0.51	0.69	0.69	0.66	0.76	0.39	0.91	0.87	0.96	0.95	0.82	0.83	0.52	1.26	1.13	0.76	0.63	0.77	1.16	0.44	0.16	0.83	0.80	1.13	0.94	2.27	1.65	0.87	1.73	0.89	0.85	1.27	0.70	0.64	1.95	1.03	0.87	1.18	1.24	0.63	1.25	1.96	1.70	1.16	0.84	0.82	0.67	0.74	1.32
glycerate	ME1042286	0.49	0.63	0.45	0.62	1.34	0.65	0.55	0.67	0.62	0.44	0.34	0.64	0.82	0.32	0.61	0.83	1.33	0.72	1.47	1.08	0.91	0.67	0.53	0.56	0.33	0.52	0.53	0.66	1.77	0.52	0.53	0.47	0.58	0.39	0.58	1.14	1.07	1.69	0.56	1.33	0.84	1.54	1.38	1.97	0.48	1.42	0.58	0.99	1.35	1.15	1.22	0.61	0.69	0.50	1.57	0.61	1.29	1.34	1.35	1.36	1.96
suberate	ME1042313	1.15	1.20	0.78	0.65	0.81	0.84	0.91	1.12	0.74	0.87	0.75	1.10	1.14	0.72	0.79	0.66	1.03	0.86	0.52	0.86	0.71	0.86	0.96	0.83	0.58	0.73	0.93	0.62	0.86	0.82	0.77	0.71	0.85	0.76	1.08	0.92	1.02	0.91	0.95	0.69	0.68	0.95	1.17	0.76	0.83	0.84	0.83	0.95	0.97	0.97	1.08	0.87	0.78	0.81	0.80	0.69	0.99	1.03	0.85	1.01	3.62
pseudouridine	ME1042307	1.40	1.23	1.01	0.78	0.95	0.84	1.00	1.83	0.95	1.11	0.88	2.22	0.55	0.97	1.11	1.53	2.05	0.79	0.68	0.84	0.72	0.95	1.25	1.10	0.54	0.80	1.04	0.59	1.14	0.77	0.80	0.71	1.12	1.23	0.86	0.88	1.02	0.95	0.62	0.72	1.01	0.96	1.04	0.77	0.70	1.12	0.82	1.45	0.88	0.92	1.13	0.75	0.90	0.97	0.88	0.67	1.02	1.08	0.87	1.02	0.83
4-hydroxybenzaldehyde	ME1042263	0.65	0.75	0.49	0.50	0.48	0.50	0.98	1.05	0.55	0.95	0.45	0.49	0.46	0.68	0.51	0.37	0.34	0.67	0.42	0.63	0.48	0.92	0.99	0.53	0.74	0.50	0.50	0.54	0.38	0.67	0.54	0.46	0.58	0.48	0.79	1.04	0.99	1.19	0.83	0.89	0.79	1.21	1.11	0.95	0.79	1.00	0.85	0.81	0.96	0.99	1.03	1.09	1.20	0.73	0.92	0.93	1.29	1.26	1.08	1.03	0.96
anhydroDglucose/3-hydroxymethylglutarate	ME1042275	1.33	1.30	0.58	0.63	0.72	0.61	0.94	1.03	1.09	0.42	0.37	0.75	0.40	0.42	0.41	1.16	0.61	0.62	0.91	0.55	0.76	0.88	0.86	0.64	0.43	0.56	0.42	0.42	0.72	0.49	0.52	0.32	0.62	0.44	0.77	1.17	0.92	0.96	0.79	0.92	1.09	1.18	1.02	1.39	0.72	0.80	0.77	0.54	0.97	1.12	1.16	1.03	0.79	0.81	1.36	0.55	1.02	1.17	0.76	1.25	1.15
uridine	ME1042323	1.40	1.14	0.85	0.50	0.54	0.77	0.98	0.88	1.17	0.64	0.64	0.50	0.63	2.05	0.78	0.77	0.83	0.78	1.15	0.76	0.71	0.97	0.91	0.81	0.67	0.85	0.83	0.95	0.52	0.81	0.81	0.63	0.50	1.15	1.47	0.95	0.92	0.65	0.81	1.33	0.60	1.04	0.93	0.50	0.56	1.26	0.80	0.64	0.82	1.06	0.96	0.64	0.94	0.85	1.16	0.88	1.09	1.10	1.20	1.96	0.76
lactate	ME1042298	1.66	1.61	1.84	0.56	0.61	0.55	1.03	1.15	0.87	0.74	0.59	0.51	0.44	0.63	0.71	1.05	1.01	1.23	0.36	0.64	0.51	1.00	1.17	0.79	0.75	0.92	0.75	0.44	0.65	0.73	0.80	0.64	1.17	0.97	0.62	1.01	1.09	1.28	1.06	0.80	0.66	0.97	0.87	1.22	1.31	0.91	0.65	0.51	0.59	0.97	1.03	1.42	0.77	0.94	0.79	0.39	0.99	1.08	0.76	1.78	0.75
aconitate	ME1042267	0.93	1.50	1.04	0.54	0.58	0.64	0.86	0.87	0.99	0.83	0.80	0.73	0.38	0.85	0.64	0.88	1.09	0.99	0.93	0.56	0.69	0.93	0.99	0.89	0.58	0.91	0.82	0.46	0.84	0.76	0.72	0.81	0.98	0.98	0.99	1.02	1.41	1.38	0.86	0.83	0.65	0.94	0.90	1.54	0.88	1.70	0.76	0.78	0.70	1.10	1.60	0.91	0.86	1.14	1.01	0.54	1.05	1.10	1.05	1.11	0.95
citrate/isocitrate	ME1042277	0.92	1.35	1.02	0.58	0.65	0.72	0.86	0.86	1.04	0.94	0.89	0.72	0.42	0.98	0.69	0.90	1.08	1.05	0.98	0.59	0.72	0.95	0.99	0.98	0.60	1.01	0.92	0.52	0.85	0.80	0.78	0.91	1.06	1.10	1.07	1.01	1.39	1.10	0.96	0.88	0.66	0.95	0.88	1.48	0.99	1.97	0.87	0.83	0.66	1.10	1.53	0.90	0.92	1.21	1.03	0.65	1.02	1.05	1.06	1.11	0.94
glycocholate-d4	ME1042251	0.80	0.76	1.08	1.21	1.29	1.27	0.98	0.91	0.91	1.03	1.16	1.34	1.35	0.87	1.16	1.09	0.97	1.26	1.47	1.25	1.19	1.01	1.00	0.95	1.45	1.25	1.06	1.23	1.13	1.10	1.03	1.45	0.93	1.06	1.21	0.99	0.96	0.84	0.87	0.96	0.96	0.99	1.04	0.90	1.10	0.92	1.01	0.95	0.96	1.00	0.96	0.93	0.94	0.88	0.95	1.37	0.98	0.98	1.00	0.85	0.97
3-methyladipate/pimelate	ME1042262	0.95	1.28	0.83	0.75	0.88	0.90	0.95	1.02	0.90	0.72	0.98	0.99	1.06	1.26	0.83	0.83	1.19	0.87	0.82	0.88	0.84	0.95	0.99	0.95	0.84	0.94	0.94	0.81	0.86	0.90	0.87	0.82	1.21	0.98	1.16	1.01	1.02	0.99	0.95	0.81	0.96	1.02	1.09	0.82	0.92	0.99	0.87	0.88	1.05	1.00	1.06	1.10	0.90	1.01	0.89	0.73	1.02	1.02	0.82	1.06	1.56
malonate	ME1042300	1.20	1.13	1.18	0.90	0.95	0.88	0.94	1.10	1.05	0.83	0.87	0.95	0.77	0.76	0.91	0.96	1.11	0.82	1.04	0.94	0.77	0.93	0.96	0.92	0.89	1.02	0.93	0.65	0.82	0.91	0.86	0.90	1.03	1.05	0.86	1.02	1.15	1.37	0.91	1.02	1.05	1.04	0.99	1.32	0.80	0.97	0.86	0.91	0.86	1.01	1.06	0.89	0.98	1.16	0.87	0.77	1.04	1.07	0.97	1.04	1.24
inosine-15N4	ME1042252	1.00	0.89	0.94	0.94	1.02	0.99	0.98	0.96	0.99	1.00	1.01	0.95	1.10	0.86	0.97	1.03	0.99	0.96	1.09	1.07	1.02	0.98	0.97	1.02	1.04	1.04	1.06	1.11	0.96	1.13	1.02	1.00	1.22	1.07	1.02	1.01	1.01	0.88	1.01	1.01	1.10	1.01	1.05	0.97	0.98	0.96	1.01	0.99	0.92	1.03	1.00	0.96	0.93	0.97	0.97	1.14	0.99	1.00	1.01	0.87	1.07
thymine-d4	ME1042253	0.96	0.88	0.99	0.96	1.02	1.05	1.01	0.96	1.02	0.99	1.08	0.87	1.13	1.08	1.06	0.99	0.90	0.95	1.04	1.05	1.02	0.99	0.99	0.94	1.01	1.02	0.97	1.08	0.93	0.98	1.01	1.03	1.01	1.07	1.01	1.02	1.01	1.02	1.00	1.03	1.02	1.01	1.00	1.06	1.01	1.00	1.01	0.98	0.84	1.01	1.00	0.97	0.99	0.99	0.91	0.96	0.99	0.98	0.96	1.00	0.98
2-aminoheptanoate	ME1042257	0.18	0.25	0.37	0.48	1.03	0.34	1.03	1.35	1.03	0.40	1.22	0.29	NA	1.12	0.70	0.49	0.33	0.89	0.33	0.25	0.25	0.74	0.72	1.57	NA	0.23	1.54	0.41	0.11	0.56	0.41	NA	NA	0.46	NA	1.57	2.01	0.25	NA	0.32	0.30	1.41	1.24	NA	0.34	0.93	0.49	0.34	0.57	0.94	1.47	0.40	0.54	0.44	0.37	NA	1.01	0.97	1.46	0.90	0.40
pantothenate	ME1042306	0.85	0.85	0.27	0.69	0.29	0.61	0.62	0.98	0.44	0.44	0.48	0.53	0.47	1.52	0.57	0.54	0.73	0.37	0.20	0.27	0.36	0.70	0.65	0.56	0.35	0.61	0.58	0.59	0.27	0.71	0.50	0.19	0.25	0.35	0.61	1.15	1.08	0.08	0.64	1.69	0.33	1.30	1.29	0.30	0.66	2.36	0.86	1.36	1.59	1.15	1.46	0.83	1.01	0.75	1.32	0.65	1.45	1.41	1.68	0.73	0.82
glucuronate	ME1042284	1.13	1.24	1.41	0.26	0.27	0.45	1.18	2.96	0.24	0.45	0.62	2.64	NA	0.03	0.60	0.75	1.72	0.50	0.06	0.09	0.42	1.10	1.59	0.73	0.02	1.63	1.34	0.08	0.38	1.06	0.92	0.28	1.38	0.66	0.56	0.69	0.85	0.18	0.04	0.32	0.36	0.78	0.84	0.42	0.45	0.32	0.24	0.82	0.58	0.71	1.56	1.03	1.07	1.30	0.59	0.05	0.85	1.08	0.20	1.01	1.51
1-methylhistidine	ME1042254	1.84	1.54	0.86	0.38	0.37	0.31	0.87	2.55	0.65	0.59	0.55	1.40	0.24	0.49	0.68	1.09	2.19	0.80	0.22	0.29	0.33	1.05	1.76	1.52	0.30	0.45	0.57	0.19	0.62	0.42	0.68	0.37	0.64	1.28	0.48	0.78	0.82	1.51	0.28	0.25	0.27	0.76	0.98	0.84	0.53	0.73	0.40	1.66	0.41	0.93	1.07	1.25	0.71	0.62	0.49	0.19	1.05	1.40	0.84	1.00	0.56
quinolinate	ME1042309	0.85	1.18	0.44	0.02	0.03	0.01	1.01	1.52	1.01	0.91	0.36	0.71	0.03	0.48	0.36	0.04	0.18	0.24	NA	0.04	0.05	1.26	1.57	1.41	0.59	0.25	0.43	0.03	0.09	0.50	0.47	0.18	0.79	0.35	0.49	1.12	1.07	2.45	0.61	0.35	0.06	0.88	0.68	0.77	0.19	0.59	0.08	0.03	0.04	1.07	0.92	1.55	0.48	0.67	0.43	0.08	0.96	0.98	0.37	0.49	0.46
2-aminobutyrate	ME1042256	1.86	1.48	1.59	0.19	0.51	0.24	1.37	1.44	0.95	0.70	0.53	0.34	0.22	1.47	0.54	0.40	0.73	0.67	0.41	0.38	0.31	1.33	1.63	1.16	0.38	0.29	0.40	0.25	0.73	0.51	0.72	0.43	0.67	0.80	0.58	0.88	1.18	1.02	0.59	0.28	0.20	0.88	0.91	0.77	0.58	0.58	0.31	0.20	0.25	0.89	0.74	1.34	0.73	0.31	0.37	0.24	0.98	0.99	0.95	1.08	0.34
urate	ME1042322	1.21	1.33	0.90	0.20	0.17	0.23	1.03	1.36	1.20	0.39	0.85	0.48	0.10	1.72	0.61	0.71	0.79	0.95	0.22	0.21	0.21	1.08	1.35	1.26	0.53	0.42	0.66	0.17	0.36	0.61	0.64	0.62	1.80	0.43	0.45	0.86	0.89	1.40	0.17	0.25	0.15	0.81	0.85	0.70	0.52	1.24	0.32	0.45	0.46	1.01	1.46	1.23	0.77	0.75	0.70	0.12	1.23	1.26	0.52	0.93	0.45

Factors:

F1	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Alive
F2	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Dead
F3	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Follow-up < 60 days
F4	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Alive
F5	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Dead
F6	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Follow-up < 60 days
F7	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Alive
F8	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Dead
F9	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Follow-up < 60 days
F10	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Dead
F11	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Follow-up < 60 days
F12	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-positive \| diagnosis:Non-infectious control \| outcome_day_60:Dead
F13	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-positive \| diagnosis:Non-infectious control \| outcome_day_60:Follow-up < 60 days
F14	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Alive
F15	Sample source:CSF \| cohort:Indonesia \| sex:Female \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Dead
F16	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Alive
F17	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Dead
F18	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Follow-up < 60 days
F19	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Alive
F20	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Dead
F21	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Follow-up < 60 days
F22	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Alive
F23	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Dead
F24	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Follow-up < 60 days
F25	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Alive
F26	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Dead
F27	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Follow-up < 60 days
F28	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:Non-infectious control \| outcome_day_60:Alive
F29	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:Non-infectious control \| outcome_day_60:Dead
F30	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Alive
F31	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Dead
F32	Sample source:CSF \| cohort:Indonesia \| sex:Male \| HIV:NA \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Alive
F33	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Alive
F34	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Dead
F35	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Follow-up < 60 days
F36	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Alive
F37	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Dead
F38	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Follow-up < 60 days
F39	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Dead
F40	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Follow-up < 60 days
F41	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-positive \| diagnosis:Non-infectious control \| outcome_day_60:Alive
F42	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Alive
F43	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Dead
F44	Sample source:CSF \| cohort:Vietnam \| sex:Female \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Follow-up < 60 days
F45	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:Alive
F46	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Alive
F47	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Alive
F48	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Dead
F49	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:Non-infectious control \| outcome_day_60:Follow-up < 60 days
F50	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Alive
F51	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Dead
F52	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-negative \| diagnosis:TBM \| outcome_day_60:Follow-up < 60 days
F53	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Alive
F54	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Dead
F55	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:Follow-up < 60 days
F56	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:Non-infectious control \| outcome_day_60:Alive
F57	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Alive
F58	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Dead
F59	Sample source:CSF \| cohort:Vietnam \| sex:Male \| HIV:HIV-positive \| diagnosis:TBM \| outcome_day_60:Follow-up < 60 days
F60	Sample source:CSF \| cohort:Vietnam \| sex:NA \| HIV:HIV-negative \| diagnosis:Bacterial meningitis \| outcome_day_60:NA
F61	Sample source:CSF \| cohort:Vietnam \| sex:NA \| HIV:HIV-positive \| diagnosis:Cryptococcal meningitis \| outcome_day_60:NA

Data matrix